vs
Astrana Health, Inc.（ASTH）与Brookfield Renewable Partners L.P.（BEP）财务数据对比。点击上方公司名可切换其他公司
Brookfield Renewable Partners L.P.的季度营收约是Astrana Health, Inc.的1.8倍（$1.7B vs $950.5M），Brookfield Renewable Partners L.P.净利率更高（5.9% vs 0.7%，领先5.2%），Astrana Health, Inc.同比增速更快（42.9% vs 14.2%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
Brookfield Renewable Partners L.P.是一家公开上市的有限合伙企业，主营可再生能源资产的持有与运营，总部位于加拿大安大略省多伦多市，60%股权由布鲁克菲尔德资产管理公司持有，在可再生能源运营领域拥有深厚的行业积累与广泛的业务布局。
ASTH vs BEP — 直观对比
营收规模更大
BEP
是对方的1.8倍
$950.5M
营收增速更快
ASTH
高出28.7%
14.2%
净利率更高
BEP
高出5.2%
0.7%
损益表 — Q4 FY2025 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $1.7B |
| 净利润 | $6.6M | $100.0M |
| 毛利率 | — | — |
| 营业利润率 | 1.9% | — |
| 净利率 | 0.7% | 5.9% |
| 营收同比 | 42.9% | 14.2% |
| 净利润同比 | 184.4% | 213.6% |
| 每股收益（稀释后） | $0.12 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHBEP
| Q4 25 | $950.5M | — | ||
| Q3 25 | $956.0M | — | ||
| Q2 25 | $654.8M | $1.7B | ||
| Q1 25 | $620.4M | — | ||
| Q4 24 | $665.2M | — | ||
| Q3 24 | $478.7M | — | ||
| Q2 24 | $486.3M | $1.5B | ||
| Q1 24 | $404.4M | — |
净利润ASTHBEP
| Q4 25 | $6.6M | — | ||
| Q3 25 | $373.0K | — | ||
| Q2 25 | $9.4M | $100.0M | ||
| Q1 25 | $6.7M | — | ||
| Q4 24 | $-7.8M | — | ||
| Q3 24 | $16.1M | — | ||
| Q2 24 | $19.2M | $-88.0M | ||
| Q1 24 | $14.8M | — |
营业利润率ASTHBEP
| Q4 25 | 1.9% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 5.9% | — | ||
| Q2 24 | 6.2% | — | ||
| Q1 24 | 7.5% | — |
净利率ASTHBEP
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 1.4% | 5.9% | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 3.4% | — | ||
| Q2 24 | 3.9% | -5.9% | ||
| Q1 24 | 3.7% | — |
每股收益（稀释后）ASTHBEP
| Q4 25 | $0.12 | — | ||
| Q3 25 | $0.01 | — | ||
| Q2 25 | $0.19 | $-0.22 | ||
| Q1 25 | $0.14 | — | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $0.33 | — | ||
| Q2 24 | $0.40 | $-0.28 | ||
| Q1 24 | $0.31 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $1.9B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $33.3B |
| 总资产 | $2.2B | $98.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHBEP
| Q4 25 | $429.5M | — | ||
| Q3 25 | $463.4M | — | ||
| Q2 25 | $342.1M | $1.9B | ||
| Q1 25 | $260.9M | — | ||
| Q4 24 | $290.8M | — | ||
| Q3 24 | $350.3M | — | ||
| Q2 24 | $327.7M | $1.2B | ||
| Q1 24 | $337.3M | — |
股东权益ASTHBEP
| Q4 25 | $779.3M | — | ||
| Q3 25 | $775.5M | — | ||
| Q2 25 | $765.5M | $33.3B | ||
| Q1 25 | $745.4M | — | ||
| Q4 24 | $712.7M | — | ||
| Q3 24 | $704.6M | — | ||
| Q2 24 | $678.9M | $28.0B | ||
| Q1 24 | $653.5M | — |
总资产ASTHBEP
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $1.4B | $98.6B | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | $73.8B | ||
| Q1 24 | $1.2B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $379.0M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | — |
| 自由现金流率自由现金流/营收 | -0.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | -0.44× | 3.79× |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势，按日历期对齐
经营现金流ASTHBEP
| Q4 25 | $-2.9M | — | ||
| Q3 25 | $10.0M | — | ||
| Q2 25 | $90.9M | $379.0M | ||
| Q1 25 | $16.6M | — | ||
| Q4 24 | $-10.9M | — | ||
| Q3 24 | $34.0M | — | ||
| Q2 24 | $23.2M | $231.0M | ||
| Q1 24 | $6.0M | — |
自由现金流ASTHBEP
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | — | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | — | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | — | ||
| Q2 24 | $20.4M | — | ||
| Q1 24 | $5.6M | — |
自由现金流率ASTHBEP
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 1.4% | — |
资本支出强度ASTHBEP
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.1% | — |
现金转化率ASTHBEP
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | 3.79× | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
BEP
暂无分部数据
